Filgrastim works by binding to specific receptors on hematopoietic cells in the bone marrow, stimulating them to proliferate and differentiate into mature neutrophils. This process helps to reduce the duration and severity of neutropenia, a common side effect of chemotherapy that leaves patients vulnerable to infections.
